Imvax
Financial Services · Biotechnology
Facts
as of Nov 17, 2026Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies.
- Legal name
- Imvax, Inc.
- Headquarters
- Philadelphia, United States
- Founded
- 2015
- Register numbers
- NAME imvax inc
- Official records
- SEC CIK 1708970
- Website
- imvax.com
These are the key facts about Imvax on Alion as of Nov 17, 2026. Imvax is headquartered in Philadelphia, United States. It was founded in 2015. It has raised $151.8M in 3 funding rounds. The latest round is Venture - Series Unknown of $112.4M, announced in 2020.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Imvax, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Philadelphia United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$151.8MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
$112.4M
$24.8M
$14.7M
Sources: funding announcements, grant and company registers
Milestones
Jul 15, 2020
Raised a round Venture round $112.4M · SEC Form D
May 10, 2019
Raised a round Venture round $24.8M · SEC Form D
2015
Founded
Each milestone is dated by its source: registers, filings, the press
